Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 8;12(8):896.
doi: 10.3390/vaccines12080896.

Mapping the Implementation Determinants of Second Dose Measles Vaccination in the World Health Organization African Region: A Rapid Review

Abdu A Adamu  1   2 , Rabiu I Jalo  3   4 , Balcha G Masresha  2 , Duduzile Ndwandwe  5 , Charles S Wiysonge  2   5
Affiliations
Review

Mapping the Implementation Determinants of Second Dose Measles Vaccination in the World Health Organization African Region: A Rapid Review

Abdu A Adamu et al. Vaccines (Basel). .

Abstract

The second dose of measles-containing vaccines (MCV2) has significant programmatic relevance in the current immunisation landscape because it serves as both an opportunity to reduce measles immunity gaps and strengthen second year of life vaccination platforms. However, MCV2 coverage remains suboptimal across countries in the World Health Organization (WHO) African Region and this puts a significant number of children at risk of morbidity and mortality from measles despite the availability of an effective vaccine. There is an urgent need to strengthen the implementation of MCV2 but this requires a thorough and systematic understanding of contextual factors that influence it. The literature that describes the determinants of implementation of MCV2 in a manner that adequately accounts for the complexity of the implementation context is scarce. Therefore, the purpose of this rapid review was to explore the implementation determinants of MCV2 in the WHO African Region using systems thinking. Literature search in two databases (PubMed and Google Scholar) were conducted. After screening, a total of 17 eligible articles were included in the study. Thematic analysis of extracted data was performed to identify the implementation determinants, after which they were mapped using the Consolidated Framework for Implementation Research (CFIR). A causal loop diagram (CLD) was used to illustrate the linkages between identified determinants. We found 44 implementation determinants across the five CFIR domains, i.e., innovation, outer setting, inner setting, individual, and implementation process. The majority of identified determinants are within the individual domain followed by the inner setting domain. The CLD showed that multiple contingent connections and feedback relationships exist between the identified implementation determinants within and across CFIR domains. The linkages between the implementation determinants revealed three balancing and reinforcing loops each. The findings suggest that implementation determinants of second-dose measles vaccination in the WHO African Region are complex, with multiple interconnections and interdependencies, and this insight should guide subsequent policies. There is an urgent need for further implementation research with embedded CLD in specific settings to inform the design of tailored systemic strategies to improve the implementation effectiveness of MCV2.

Keywords: WHO African Region; childhood vaccination; consolidated framework for implementation research; implementation determinants; measles-containing vaccines; primary health care.

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests. The authors alone are responsible for the views expressed in this article and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated.

Figures

Figure 1
Figure 1
PRISMA flow diagram for the study.
Figure 2
Figure 2
Radar chart showing number of publications per year from 2017 to 2024.
Figure 3
Figure 3
Causal loop diagram of the implementation determinants of second dose measles vaccination.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Robbins F.C. Measles: Clinical Features: Pathogenesis, Pathology and Complications. Am. J. Dis. Child. 1962;103:266–273. doi: 10.1001/archpedi.1962.02080020278018. - DOI - PubMed
    1. Guerra F.M., Bolotin S., Lim G., Heffernan J., Deeks S.L., Li Y., Crowcroft N.S. The Basic Reproduction Number (R0) of Measles: A Systematic Review. Lancet Infect. Dis. 2017;17:e420–e428. doi: 10.1016/S1473-3099(17)30307-9. - DOI - PubMed
    1. Hedrich A.W. Monthly Estimates of the Child Population “Susceptible’ to Measles, 1900–1931, Baltimore, MD. Am. J. Epidemiol. 1933;17:613–636. doi: 10.1093/oxfordjournals.aje.a117929. - DOI
    1. Perry R.T., Halsey N.A. The Clinical Significance of Measles: A Review. J. Infect. Dis. 2004;189:S4–S16. doi: 10.1086/377712. - DOI - PubMed
    1. Buchanan R., Bonthius D.J. Measles Virus and Associated Central Nervous System Sequelae. Semin. Pediatr. Neurol. 2012;19:107–114. doi: 10.1016/j.spen.2012.02.003. - DOI - PubMed

LinkOut - more resources